Detection and clinical significance of plasma glutathione-S-transferases in dogs with lymphoma

In Vivo

Volumn 13, Issue 2, 1999, Pages 173-175

  Hahn, Kevin A ^a   Barnhill, Mary A ^a   Freeman, Kimberly P ^a   Shoieb, Ahmed M ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Animal model; Canine; Glutathione S transferase; Lymphoma

Indexed keywords

ANTHRACYCLINE; DOXORUBICIN; GLUTATHIONE TRANSFERASE; IMMUNOGLOBULIN G;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOMA; NONHUMAN; RECURRENT CANCER;

EID: 0032919121     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Beckett GJ, Hayes JD: Glutathione-S-transferases: biomedical applications Advan Clin Chem 30: 281-380, 1993.
2. Tew KD: Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54: 4313-4320, 1994.
3. Mannervik B, Guthenberg C, Jensson H, Warholm - M, Alin P. Isozymes of glutathione-S-transferases in rat and human tissues. In: Functions of glutathione: Biochemical, physiological, toxicological and clinical aspects (A Larsson, S Orrenius, A Holmgren, and B Mannervik eds). New York, Raven Press, 1983, pp 75-88.
4. Tu C-PD, Weiss MN, Li N, Reddy CC. Tissue-specific expression of the rat glutathione S-transferases. J Biol Chem 258: 4659-4662, 1983.
5. Mannervik B, Alin P, Guthenberg C. Identification of three classes of cytosolic glutathione transferase common to several mammalian species: Correlation between structural data and enzymatic properties. Proc Natl Acad Sci USA 82: 7202-7206, 1985.
6. Schisselbauer JC, Silber R, Papadopoulos E, Abrams K, LaCreta FP, Tew KD: Characterization of lymphocyte glutathione-S-transferase isozymes in chronic lymphocytic leukemia (CLL). Cancer Res 50: 3569-3573, 1990.
7. Hirata S, Odajima T, Kohama G, Ishigaki S, Niitsu Y. Significance of glutathione-S-ransferase π as a tumor marker in patients with oral cancer. Cancer 70: 2381-2387, 1992.
8. Toffoli G, Viel A, Tumiotto L, Giannini F, Volpe R, Quaia M, Boiocchi M: Expression of glutathione-S-transferase π in human tumors. Eur J Cancer 28: 1441-1446, 1992.
9. Hall AG, Autzen P, Cattan AR, Malcolm AJ, Cole M, Kernahan J, Reid MM: Expression of μ class glutathione-S-transferase correlates with event-free survival in childhood acute lymphoblastic leukemia. Cancer Res 54: 5251-5254, 1994.
10. Mulder TP, Verspaget HW, Sier CF, Roelofs HM, Ganesh S, Griffioen G, Peters WH: Glutathione-S-transferase π in colorectal tumors is predictive for overall survival. Cancer Res 55: 2696-2702, 1995.
11. Szarka CE, Pfeiffer GR, Hum ST, Everley LC, Balshem AM, Moore DF, Litwin S, Goosenberg EB, Frucht H, Engstrom PF: Glutathione-S-transferase activity and glutathione-S-transferase mu expression in subjects with risk for colorectal cancer. Cancer Res 55: 2789-2793, 1995.
12. Hahn KA, Richardson RC, MA Cline, Teclaw RF, Carlton WW, DeNicola DB, Bonney PL: Is maintenance chemotherapy appropriate for the management of canine malignant lymphoma? J Vet Int Med 6: 3-10, 1992.
13. th Edition (JF Holland, RC Bast, DL Morton, E Frel, DW Kufe, RR Weichselbaum, eds). Philadelphia, Williams & Wilkins Co, 1997, pp 2757-2796.
14. Lee JJ, Hughes CS, Fine RL, Page RL: P-glycoprotein expression in canine lymphoma: a relevant, intermediate model of multidrug resistance. Cancer 77: 1982-1988, 1996.
15. Ginn PE: Immunohistochemical detection of P-glycoprotein in formalin-fixed and paraffin-embedded normal and neoplastic canine tissues. Vet Pathol 33: 533-541, 1996.
16. Shoieb AS, Hahn KA: Detection and significance of glutathione-S-transferase π in osteogenic tumors of dogs. Intl J Oncology 10: 635-639, 1997.
17. Shoieb AM, Hahn KA, van Laack RL, Barnhill MA: In vitro reversal of glutathione-S-transferase-mediated resistance in canine osteosarcoma (COS31) cells. In Vivo 12: 455-462, 1998.
18. Owen LN: TNM classification of tumours in domestic animals. World Health Organization, Geneva, 1980.
19. Steel RGD, Torrie JH: Observations In: Principles and Procedures of Statistics (RGD Steel and JH Torric, eds). New York, McGraw-Hill, 1980, pp 8-38.
20. Waxman DJ: Glutathione-S-transferases: Role in alkylating agent resistance and possible target for modulation chemotherapy. Cancer Res 50: 6449-6454, 1990.
21. Cummings J, Willmott N, Hoey BM, Marley ES, Smyth JF: The consequences of doxorubicin quinone reduction in vivo in tumor tissue. Biochem Pharmacol 44: 2165-2174, 1992.
22. Gottesman MM. How cancer cells evade chemotherapy. Cancer Res 53: 747-754, 1993.
23. Hansson J, Edgren M, Ehrsson H, Ringborg U, Nilsson B: Effect of D,L-buthionine-S,R-sulfoximine on cytotoxicity and DNA cross-linking induced by bifunctional DNA-reactive cytostatic drugs in human melanoma cells. Cancer Res 48: 19-26, 1988.
24. Goodman J, Hochstein P. Generation of free radicals and lipid peroxidation by redox recycling of adriamycin and daunomycin. Biochem Biophys Res Commun 77: 797-803, 1977.
25. Goto S, Yoshida K, Morikawa T, Urata Y, Suzuki K, Kondo T: Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells. Cancer Res 55: 4297-4301, 1995.
26. Richardson ME, Siemann DW: DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione. Cancer Res 55: 1691-1695, 1995.
27. Igarashi T, Kohara A, Shikata Y, Sagami F, Sonoda J, Horie T, Satoh T: The unique feature of dog liver cytosolic glutathione-S-transferases. J Biol Chem 266: 21709-21717, 1991.
28. Igarashi T, Nanba E, Sagami F, Tsukidate K, Fukuda T, Horie T, Satoh T, Kitagawa H: Dog liver glutathione-S-transferase and its strong immunoreactivity with rat transferase-P(7-7). Biochem Pharmacol 37: 4713-4718, 1988.